Press Releases Cardiff Oncology, Inc.

Equities

CRDF

US14147L1089

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-24 pm EDT			5-day change	1st Jan Change
3.44 ^USD	+4.24%		-5.23%	+132.43%

May. 02	Transcript : Cardiff Oncology, Inc., Q1 2024 Earnings Call, May 02, 2024
May. 02	Cardiff Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cardiff Oncology to Present at Upcoming Investor Conferences in May	May. 13	AQ
Cardiff Oncology: Q1 Earnings Snapshot	May. 02	AQ
Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update	May. 02	AQ
Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update	Apr. 25	AQ
Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study	Apr. 08	AQ
Thinking about buying stock in Cardiff Oncology, BIOLASE, Akebia Therapeutics, Astera Labs, or Atossa Therapeutics?	Mar. 26	PR
Cardiff Oncology Announces Upcoming Presentations at the AACR Annual Meeting 2024	Mar. 06	AQ
Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update	Feb. 29	AQ
Cardiff Oncology Provides Clinical Update on Phase 2 Randomized Second-line ONSEMBLE Trial in Patients with RAS-mutated mCRC	Feb. 29	AQ
Cardiff Oncology Announces First Patient Dosed in Randomized First-line RAS-mutated Metastatic Colorectal Cancer Trial (CRDF-004)	Feb. 29	AQ
Cardiff Oncology to Present at the Cowen 44th Annual Health Care Conference	Feb. 26	GL
Cardiff Oncology to Present at the Cowen 44th Annual Health Care Conference	Feb. 26	AQ
Cardiff Oncology to Report Fourth Quarter and Full Year 2023 Results and Provide Business Update	Feb. 22	GL
Cardiff Oncology to Report Fourth Quarter and Full Year 2023 Results and Provide Business Update	Feb. 22	AQ
Cardiff Oncology Announces Publication of Data from Phase 1b study in second-line KRAS-mutated mCRC in Clinical Cancer Research	Jan. 18	AQ
Cardiff Oncology to Present at the 35th Annual Piper Sandler Healthcare Conference	Nov. 20	PR
Cardiff Oncology: Q3 Earnings Snapshot	Nov. 02	AQ
Cardiff Oncology Reports Third Quarter 2023 Results and Provides Business Update	Nov. 02	PR
Cardiff Oncology to Report Third Quarter 2023 Financial Results and Provide Business Update	23-10-26	PR
Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib Monotherapy	23-09-26	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Cardiff Oncology, Inc.

Equities

CRDF

US14147L1089

Press Releases

Filters